IMIDomics

    OverviewSuggest Edit

    IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients. It utilizes a platform that integrates access to a dynamic IMID patient biobank, curated clinical data, proprietary multiomics molecular data, and clinical expertise. IMIDomics analytics platform extracts insights into disease biology and patient conditions through a proprietary interactive portal.
    TypePrivate
    Founded2015
    Websiteimidomics.com

    Latest Updates

    Employees (est.) (May 2020)3
    Cybersecurity ratingBMore

    IMIDomics Financials and Metrics

    Summary Metrics

    Founding Date

    2015

    IMIDomics Cybersecurity Score

    Cybersecurity ratingPremium dataset

    B

    81/100

    SecurityScorecard logo

    IMIDomics Online and Social Media Presence

    Embed Graph

    IMIDomics Frequently Asked Questions

    • When was IMIDomics founded?

      IMIDomics was founded in 2015.

    • How many employees does IMIDomics have?

      IMIDomics has 3 employees.

    • Who are IMIDomics competitors?

      Competitors of IMIDomics include ImevaX, Appello Pharmaceuticals and BioArctic.